Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
DiaMedica Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
DMAC
Nasdaq
8731
https://www.diamedica.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for DiaMedica Therapeutics Inc
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcript
- Mar 25th, 2024 2:00 pm
DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) Path To Profitability
- Mar 21st, 2024 10:14 am
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
- Mar 19th, 2024 8:15 pm
DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference
- Jan 29th, 2024 9:13 pm
DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
- Jan 22nd, 2024 1:23 pm
DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 52% ownership, insiders own 37%
- Jan 7th, 2024 12:27 pm
Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation
- Dec 11th, 2023 11:16 am
Billionaire Lee Cooperman’s 10 Stock Picks with Huge Upside Potential
- Dec 4th, 2023 7:56 pm
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript
- Nov 15th, 2023 5:15 pm
Q3 2023 DiaMedica Therapeutics Inc Earnings Call
- Nov 15th, 2023 3:54 am
DiaMedica Therapeutics Inc. (DMAC) Reports Third Quarter 2023 Financial Results
- Nov 14th, 2023 7:53 pm
DiaMedica Therapeutics Insiders Placed Bullish Bets Worth US$20.2m
- Nov 14th, 2023 11:02 am
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
- Nov 13th, 2023 9:28 pm
DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023
- Nov 9th, 2023 1:25 pm
DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023
- Nov 6th, 2023 1:23 pm
DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer
- Sep 12th, 2023 12:13 pm
DiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth Conference
- Sep 6th, 2023 12:35 pm
Is DiaMedica Therapeutics (DMAC) Stock Outpacing Its Medical Peers This Year?
- Aug 31st, 2023 1:40 pm
Q2 2023 DiaMedica Therapeutics Inc Earnings Call
- Aug 16th, 2023 1:19 am
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
- Aug 14th, 2023 8:13 pm
Scroll